Ain Holdings Inc. · TSE:9627
Ain — FY4/23 Earnings Presentation
29 slides from Ain's earnings presentation, Jun 7, 2023
Slide 1: FY4/23 IR Presentation
FY4/23 IR PRESENTATION June 2023
Slide 2: Results Overview
Results Overview © 2023 AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales increased 13.4% YoY and 0.2% against the plan due to new store openings and contribution of existing stores, despite the impact of the COVID-19. Ordinary profit increased 6.4% YoY and declined 5.4% against the plan due to increase of sales. FY4/22 FY4/23 FY4/23 YoY YoY Vs
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 13.6% YoY and 0.0% against the plan due to new store openings including M&A and contribution of stores opened previous year. Segment profit declined 3.8% YoY and 5.4% against the plan. FY4/22 FY4/23 FY4/23 YoY YoY Vs plan （¥ million） re
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Net sales increased 24.9% YoY and 3.1% against the plan due to the recovery of existing stores, contribution of stores opened in previous year, and success of cost optimization despite the impact of the COVID-19. Segment profit was 38% against the plan
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥37,804 million and shareholders’ equity ratio became 54.6%. We are maintaining a sound financial structure. End-FY4/22 (¥ million) End-FY4/23 (¥ million) Assets Liabilities Assets Liabilities Current assets Current Current assets Current 100,765 81,805 98,305 92,986
Slide 7: Assets
Assets The balance of total assets increased ¥19,289 million from the end of the previous fiscal year due to decrease of cash on hand and in banks and increase of inventories and goodwill. (¥ million) End-FY4/21 End-FY4/22 End-FY4/23 Change Cash on hand and in banks 55,271 59,729 46,796 (12,933) Not
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets Accounts payable increased ¥7,942 million due to new store openings including M&A. Short- term and long-term debt increased ¥233 million. (¥ million) End-FY4/21 End-FY4/22 End-FY4/23 Change Accounts payable 46,758 50,756 58,698 ＋7,942 Short-term debt 3,670 2,643 3,670 ＋1,0
Slide 9: Consolidated C/F
Consolidated C/F Decrease of Net cash used in investing activities expanded to ¥22,292 million due to large-scale M&A. Cash and cash equivalents at the end of the year are still ample, despite decrease of ¥13,253 million from the previous fiscal year. (¥ million) FY4/22 FY4/23 Change Net cash provid
Slide 10: Business Value Analysis
Business Value Analysis FY4/21 FY4/22 FY4/23 Change Shareholders’ equity ratio (%) 56.8 56.0 54.6 (1.4) Market value equity ratio (%) 105.6 96.6 85.5 (11.1) PER (times) 32.11 28.99 21.46 (7.53) EPS (¥) 189.04 201.47 262.87 ＋61.40 PBR (times) 1.86 1.74 1.58 (0.16) BPS (¥) 3,267.49 3,385.51 3,599.47 ＋
Slide 11: FY4/24 Plan (Consolidated)
FY4/24 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2024 increase 4.5% YoY due to our plans to open 50 dispensing pharmacies and 12 cosmetic and drugstores. Ordinary profit will decrease 4.5% due to rising prices, increase in costs of DX investment and proce
Slide 12: Review
Review © 2023 AIN HOLDINGS INC. All Rights Reserved. 11
Slide 13: Review (YoY)
Review (YoY) Ordinary profit increased ¥1.0 billion due to increase of net sales in dispensing pharmacy business and cosmetic and drugstore business, etc. Net sales Ordinary profit ¥358.7 billion +¥42.5 billion ¥17.0 billion +¥1.0 billion ¥16.0 billion ¥316.2 billion +13.4% +6.4% ■Dispensing Pharmac
Slide 14: Review (Revised plan)
Review (Revised plan) Net sales increased ¥0.7 billion due to decrease of gross profit in dispensing pharmacy business. Ordinary profit decreased 1.0billion. Net sales Ordinary profit ＋¥(1.0) billion ¥358.0 billion ¥358.7 billion +¥0.7 billion +(5.4)% ¥18.0 billion ■Dispensing +0.2% ¥17.0 billion Ph
Slide 15: Strategy
Strategy © 2023 AIN HOLDINGS INC. All Rights Reserved. 14
Slide 16: Strategy
Strategy Expansion of top-line and increase profits ■Dispensing Pharmacy Plan to open 50 pharmacies（Organic 30, M&A 20） ■Cosmetic and Drug Store Plan to open 12 stores Recruiting and training of human resources ■Planning to hire 650 newly graduated pharmacists and 400 medical staff ■Make Field Manag
Slide 17: Expansion of top-line and increase profits
Expansion of top-line and increase profits ■Dispensing Pharmacy Plan to open 50 pharmacies（Organic 30, M&A 20） ■Cosmetic and Drug Store Plan to open 12 stores ■ Top-line ¥316.2 billion +13.4%¥358.7 billion +4.5% ¥375.0 billion ■Dispensing Pharmacy ¥283.1 billion ¥321.5 billion ¥336.1 billion ■Cosmet
Slide 18: Expansion of top-line and increase profits
Expansion of top-line and increase profits ■Dispensing Pharmacy Plan to open 50 pharmacies（Organic 30, M&A 20） ■Cosmetic and Drug Store Plan to open 12 stores FY4/23 Results FY4/24 Plan 110 1,287 1,337 18 Dispensing Dispensing Pharmacies 1,209 Pharmacies 1,249 Cosmetics and 78 Cosmetics and 88 165 D
Slide 19: Store openings and closures
Expansion of top-line and increase profits ■Dispensing Pharmacy Plan to open 50 pharmacies（Organic 30, M&A 20） ■Cosmetic and Drug Store Plan to open 12 stores ■ Plan FY4/23 FY4/24 Revised Plan Results Plan Dispensing Pharmacy 141 141 50 Organic 27 27 30 Opening M&A 114 20 114 Cosmetic and drug store
Slide 20: Recruiting and training of human resources
Recruiting and training of human resources ■Planning to hire 650 newly graduated pharmacists and 400 medical staff ■Make Field Manager system and Medical Supervisor system more established ■Training of human resources In April 2023, new 543 pharmacists has joined our group. We aim to hire, new 650 p
Slide 21: Reinforcing the Group's business base
Reinforcing the Group’s business base ■Improving the customer services by promoting DX, such as official apps ■Promoting Sustainable Management We have conducted our corporate activities with common sense and ethics in order to realize our group statement of “the health and happiness of our customer
Slide 22: Reinforcing the Group's business base
Reinforcing the Group’s business base ■Improving the customer services by promoting DX, such as official apps ■Promoting Sustainable Management Sustainability Committee has been established across departments and positions within our company, and approximately 30 project teams are promoting cross- s
Slide 23: Turnaround and expansion of AINZ&TULPE
Turnaround and expansion of AINZ&TULPE ■Opening stores in prime locations and medium and long term plans to open new stores AINZ & TULPE opened in FY4/23 8 stores CELEO KOKUBUNJI (Mar. 2023 ） HOKKAIDO BALL PARK (Mar. 2023 ） KOBE MOTOMACHI （Jun. 2022） FUTAKOTAMAGAWA RISE S.C SAPPORO STELLA PLACE （Oct
Slide 24: Turnaround and expansion of AINZ&TULPE
Turnaround and expansion of AINZ&TULPE ■Opening stores in prime locations and medium and long term plans to open new stores AINZ & TULPE plan to open in FY4/24 12 stores (Tentative) COCONO SUSUKINO (Plan to open in Nov. 2023 ) Tokyo (Plan to open in Feb. 2024 ) Kanagawa COCORIA TAMA CENTER （ Plan to
Slide 25: FY4/24 Plan Dispensing Pharmacy Business
FY4/24 Plan Dispensing Pharmacy Business The group forecasts net sales for the fiscal year ending April 30, 2024 increase 4.5% YoY due to our plans to open 50 dispensing pharmacies and close 10 dispensing pharmacies. Segment profit will increase 0.6%. FY4/22 FY4/23 FY4/24 YoY YoY （¥ million） results
Slide 26: FY4/24 Plan Cosmetic and Drug Store Business
FY4/24 Plan Cosmetic and Drug Store Business The group forecasts net sales for the fiscal year ending April 30, 2024 increase 6.1% YoY due to our plans to open 12 cosmetic and drugstores and close 2 cosmetic and drugstores . Segment profit will increase 12.9%. FY4/22 FY4/23 FY4/24 YoY YoY （¥ million
Slide 27: FY4/24 Plan (Consolidated)
FY4/24 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2024 increase 4.5% YoY due to our plans to open 50 dispensing pharmacies and 12 cosmetic and drugstores. Ordinary profit will decrease 4.5% FY4/22 FY4/23 FY4/24 YoY YoY （¥ million） results results plan chan
Slide 28: AIN HOLDINGS INC. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document ha
Slide 29: AIN GROUP
AIN GROUP